| USD millions | FY2025 | TTM |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Cost of revenue | 0.1 | 0.0 |
| Gross profit | (0.1) | 0.0 |
| Research & development | 0.0 | — |
| Selling, general & administrative | 0.5 | — |
| Selling & marketing | 0.0 | — |
| Operating expenses | 0.3 | — |
| Operating income | (0.5) | (0.8) |
| Interest expense | 0.0 | — |
| Interest income | 0.0 | 0.0 |
| Other income / expense | 5.5 | — |
| Pre-tax income | 5.1 | 8.1 |
| Income tax | 0.0 | 0.0 |
| Net income | 5.1 | 8.1 |
| Discontinued operations | 0.0 | — |
| Other net income adjustments | 0.0 | — |
| EPS, basic (per share) | 0.23 | 0.26 |
| EPS, diluted (per share) | 0.23 | 0.26 |
| EBITDA | (0.6) | (0.8) |
| Depreciation & amortization | 0.0 | — |
| Weighted average shares (shares) | 21,709,226 | — |
| Weighted average diluted shares (shares) | 21,865,199 | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.